Shuoyang Huang
Overview
Explore the profile of Shuoyang Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wen Y, Wang X, Si K, Xu L, Huang S, Zhan Y
Curr Comput Aided Drug Des
. 2023 May;
20(5):534-550.
PMID: 37190808
Background: Ulcerative colitis (UC) and irritable bowel syndrome (IBS) are common intestinal diseases. According to the clinical experience and curative effect, the authors formulated Kuiyu Pingchang Decoction (KYPCD) comprised of...
2.
Li X, Song D, Su S, He X, Cao F, Yang C, et al.
Front Genet
. 2022 Oct;
13:984615.
PMID: 36246628
The guanylate-binding proteins (GBPs) are the latest potential targets of immunotherapy. However, the role of GBP5 in pan-cancer, including colorectal cancer (CRC), remains unclear. This study aims to explore the...
3.
Yang C, Huang S, Cao F, Zheng Y
BMC Cancer
. 2021 Nov;
21(1):1182.
PMID: 34740325
Background And Aim: Lipid metabolic reprogramming is considered to be a new hallmark of malignant tumors. The purpose of this study was to explore the expression profiles of lipid metabolism-related...
4.
Yang C, Cao F, Huang S, Zheng Y
Front Immunol
. 2021 Aug;
12:717505.
PMID: 34335633
Background: As a heterogeneous disease, colorectal cancer (CRC) presents a great challenge to individualized treatment due to its lymph node metastasis (LNM). Existing studies have shown that immune and stromal...
5.
Yang C, Huang S, Cao F, Zheng Y
PeerJ
. 2021 Jul;
9:e11745.
PMID: 34316400
Background And Aim: Colorectal cancer (CRC) ranks the second most common cause of cancer-related mortality worldwide. Ferroptosis, a recently discovered form of programmed cell death different from other, raises promising...
6.
Li H, Yang C, Cheng H, Huang S, Zheng Y
J Cancer
. 2021 Feb;
12(6):1804-1814.
PMID: 33613769
Chimeric antigen receptor-T (CAR-T) cell immunotherapy is a novel method that is genetically engineered to recruit T cells against malignant disease. Administration of CAR-T cells has led to progress in...